Large Study Finds No Survival Benefit Associated With Removal Of Ovaries
ASCO Advises KRAS Testing In Patients With Metastatic Colorectal Cancer
Study Links Obesity To Higher Risk of Ovarian Cancer
Xeloda + Oxaliplatin Compares To FOLFOX-4 In First Line
Pre-Emptive Treatment Helped Curtail Panitumumab Toxicity
Early HER2 Positive Patients At Higher Risk of Recurrence
Tykerb Plus Letrozole Delayed Metastatic Breast Cancer
Estrogen Can Benefit Women With Metastatic Breast Cancer
Alternating Mammography, MRI Tested For High-Risk Women
Degarelix Approved For Advanced Prostate Cancer
NCI Cooperative Group, Cancer Center Trials Listed
Trending Stories
- Brawley: ACS prostate cancer screening guideline should say no to “mass screening”
- NCI’s Letai, FDA’s Diamantas identify strategies to speed up cancer trials
Letai: 150 days to start a cancer trial is too long—cancer centers need to accept a little risk - ACS strengthens recommendation for prostate cancer screening
Many will hear the endorsement and ignore the limitations - Kay “Taddy” Dickersin, NBCC co-founder, dies at 74
- CMS rule cuts overall oncology payments by estimated 2%
Final rule slashes 340B, moves toward site-neutrality - Is it time to re-assess the practice and practicality of screening colonoscopy?
Modeling data, ACS guideline support greater use of noninvasive tests to ease system strain, help save lives









